仁和中方医药股份有限公司

What 仁和中方医药股份有限公司 does

仁和中方医药股份有限公司 (Jiangxi Renhe Zhongfang Pharmaceutical Co., Ltd.) is a privately-held pharmaceutical wholesale and marketing enterprise established on December 10, 2009, headquartered in Jiangxi Province's Zhangshu City — historically recognized as China's "Pharmaceutical Capital" (中国药都). The company is a wholly-controlled subsidiary of listed Renhe Pharmaceutical Co., Ltd. (仁和药业股份有限公司, Shenzhen Stock Exchange ticker 000650) and operates as the group's core backbone marketing enterprise (骨干销售企业). Its functional role is nationwide distribution and marketing of the parent group's pharmaceutical portfolio to retail pharmacy chains and independent drugstores across all 30 provinces, municipalities, and autonomous regions of mainland China, under a strict regional protection model designed to preserve market order and terminal-level price stability.

The company's product platform comprises 262 marketed products organized across 10+ therapeutic series — including cold/inflammatory remedies, pediatrics, gynecology, blood circulation, digestive, tonic/nourishing, ophthalmology, cardiovascular, topical ointments, ENT/skin, vitamins/minerals, heat-clearing, and antibiotics — anchored by structured sub-brands: 闪亮 (Shanliang) for ophthalmology, 米阿卡 (Miaka) for pediatrics, 克快好 (Kekuaihao) for cough, 清火 for heat-clearing, plus tonic and chronic disease product lines. The portfolio includes 26 National Essential Medicine List entries and 15 nationally exclusive products. Recent SKU additions visible on the company website extend into ophthalmology prescription-adjacent products (moxifloxacin, diquafosol sodium), cardiovascular (levamlodipine, ginkgo biloba), ED treatment, medical devices (Type III collagen dressings, hyaluronic acid gel), and dietary supplements.

Revenue is generated through wholesale distribution of OTC and prescription pharmaceutical products under a sales-led go-to-market model executed via dedicated provincial/regional field sales teams, terminal-level 带教 (coaching) programs, and an internal training platform (仁和中方大讲堂/仁和中方商学院). The company is a vice-chairman unit of the China Medical Materials Association (中国医药物资协会), holds an Internet Drug Information Service Qualification Certificate, and as of March 2026 has entered a strategic partnership with 安徽邻医数智科技 to deploy a full-channel compliance management direct-connection system for channel control. No public revenue, headcount, or financial disclosures are available; the company's most visible scale signal is its 1,000+ personnel scale noted at its 2017 annual sales conference, materially larger than the 11-50 figure listed in firmographic records.

Name

仁和中方医药股份有限公司

Legal name

江西仁和中方医药股份有限公司

Website

https://zfrenhe.com

Company type

Private

Founded year

2009

Operating status

Operating

Headcount range

11–50 employees

Short description

Jiangxi Renhe Zhongfang Pharmaceutical is the wholly-owned marketing and distribution subsidiary of listed Renhe Pharmaceutical (000650), wholesale-distributing a 262-product OTC and TCM portfolio across 30 Chinese provinces to retail pharmacies via regional field-sales teams and sub-brands including 闪亮, 米阿卡, and 克快好.

Ownership category

akta.pro rank

Product category

OTC Pharmaceutical Distribution

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (424210)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

OTC Medicines & Consumer Health Products Distribution (CRAOAHAB)

akta.pro secondary industry

Pharmacy Front-End & Sundries Distribution (Health & Wellness, Personal Care, Convenience) (CRAOAHAG)

Keywords

• Pharmaceutical distribution
• OTC medicines
• Chinese patent medicines
• Retail pharmacy supply
• Pharmaceutical marketing

Headquarters

HQ city

樟树市

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Marketing or Sales, Personnel, Operations, Supply Chain, Technology or R&D

Revenue model

1. Pharmaceutical Product Wholesale Distribution: 仁和中方 generates revenue primarily through the wholesale distribution of pharmaceutical products (OTC and prescription drugs) to retail pharmacy chains, independent drugstores, and hospitals across China. The company holds licenses for wholesale of Chinese herbal slices, Chinese patent medicines, chemical raw materials and preparations, antibiotics, biochemical drugs, pre-packaged foods, health food, Class I and II medical devices, disinfectants, and cosmetics. Revenue is driven by a portfolio of 262 marketed products across 10+ therapeutic categories.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels6 records

Core offering

仁和中方医药股份有限公司 is a pharmaceutical wholesale distribution enterprise and core marketing subsidiary of listed company Renhe Pharmaceutical (Shenzhen A-share, stock code 000650). The company markets and distributes a 262-product OTC pharmaceutical portfolio spanning 10+ therapeutic categories to retail pharmacy chains and independent drugstores across all 30 provinces, municipalities, and autonomous regions of China under a strict regional protection marketing model. The portfolio covers Chinese herbal slices, Chinese patent medicines, chemical APIs/preparations, antibiotics, biochemical drugs, health foods, Class I and II medical devices, disinfectants, and cosmetics, organized under branded product lines including 闪亮 (Shanliang) eye care, 米阿卡 (Miaka) pediatric, 克快好 (Kekuaihao) cough, 清火 (Qinghuo) heat-clearing, 补益 (tonic), and 慢病 (chronic disease) product lines.

Product overview

仁和中方医药股份有限公司 is a pharmaceutical wholesale company and core marketing subsidiary of Renhe Pharmaceutical (stock code 000650), operating as a unified product portfolio distributed through a nationwide marketing network across 30 provinces. The company offers 262 products including 26 national essential drug list products and 15 nationally exclusive products. The portfolio is organized around five key brand series: 闪亮系列 (Shanliang Eye Care Brand) featuring ophthalmic products like 复方门冬维甘滴眼液, 萘敏维滴眼液, 硫酸锌尿囊素滴眼液, 地夸磷索钠滴眼液, 盐酸莫西沙星滴眼液, 清热明目茶, and 不老莓叶黄素酯DHA软糖; 米阿卡系列 (Miaka Pediatric Brand) featuring pediatric formulations like 布洛芬混悬液, 蒙脱石散, 儿宝颗粒, 抗病毒口服液, 小儿咽扁颗粒, 健儿消食口服液, and 头孢地尼颗粒; 克快好系列 (Kekuaihao Cough Brand) featuring cough products like 盐酸氨溴索分散片 and 川贝清肺糖浆; 补益产品线 (Tonic Product Line) featuring products like 六味地黄丸, 补肾益寿片, 蚝贝钙咀嚼片, 龟鹿二仙膏, and 龟甲胶; and 慢病产品线 (Chronic Disease Management Line) featuring cardiovascular and chronic disease products like 银杏叶软胶囊, 苯磺酸左氨氯地平片, and 奥美拉唑肠溶片. The company also offers topical ointments (外用膏剂类), ENT/skin products (五官皮肤类), digestive products (消化系统类), cold medications (感冒类), heat-clearing products (清热解毒清火类), antibiotics (抗菌消炎类), and vitamins/minerals (维生素矿物质类).

Differentiator

Problem solved

Functional benefit

Brands

• 闪亮系列: Eye care product line including eye drops such as compound aminomethylvitamin eye drops, naphazoline hydrochloride eye drops, sodium zinc allantoinate eye drops, and dietary supplements like black chokeberry lutein ester DHA gummies
• 米阿卡系列
• 克快好系列
• 清火胶囊
• 大活络丸

Products and services

• 闪亮系列眼健康产品 (Shanliang Eye Care Series) Brand-level OTC ophthalmic product line comprising multiple eye drop formulations (compound menadione, naphazoline, sodium chloride, moxifloxacin, diquafosol sodium, zinc sulfate allantoin, compound urine vitamin ammonia), eye-health dietary supplements (aronia lutein ester DHA gummies), and heat-clearing eye-benefiting tea. Indicated for eye fatigue, conjunctival congestion, eye itching, dry eye disease, bacterial conjunctivitis, and vision protection. Sold through retail pharmacy chains and independent drugstores across China.
• 米阿卡系列儿科产品 (Miaka Pediatric Series) Brand-level OTC pediatric product line covering fever/pain relief (ibuprofen suspension, acetaminophen granules, medical fever cooling patch), gastrointestinal care (montmorillonite powder, jianer xiaoshi oral liquid, erbao granules), respiratory care (antiviral oral liquid, children's yanbian granules), wound care (lidocaine chlorhexidine aerosol), nutritional supplementation (compound zinc iron calcium oral solution, zinc gluconate oral solution, codonopsis poria oral liquid), and antibiotic therapy (cefdinir granules). Sold through retail pharmacies across China.
• 克快好系列止咳产品 (Kekuaihao Cough Series) Brand-level OTC cough and phlegm-relief product line comprising ambroxol hydrochloride dispersible tablets for difficult-to-expectorate viscous sputum and chuanbei qingfei syrup for lung heat, dry cough, sore throat, and phlegm resolution. Sold through retail pharmacies across China.
• 清火胶囊 (Qinghuo Jiaonang) Flagship heat-clearing and fire-reducing capsule (清热泻火，通便) for treating sore throat, toothache, headache/dizziness, mouth sores, red eyes, wind-fire congestion, and constipation. Marketed as a key product in the 清火 (Qinghuo) brand line and distributed through retail pharmacies nationwide.
• 大活络丸 (Da Huo Luo Wan) Flagship gold single product containing 48 precious herbal ingredients including Qi She (agkistrodon), Wu Shao She (zaocys dhumnades), and Ren Shen (ginseng). Indicated for wind-stroke, phlegm reversal, lumbar and leg pain, and traumatic injuries. Won the 2026 West Lake Award "Most Popular Star Single Product in Pharmacies" at the Wuzhen Health Conference.
• 消炎镇痛膏 (Xiaoyan Zhentong Gao) OTC anti-inflammatory and analgesic medicated patch for nerve pain, rheumatism, shoulder pain, sprains, joint pain, and muscle pain. Distributed through retail pharmacies nationwide.
• 桂龙咳喘宁片 (Guilong Kechuanning Pian) OTC cough and asthma relief tablet (止咳化痰，降气平喘) for treating cough, asthma, and phlegm congestion caused by wind-cold or phlegm-dampness; indicated for acute and chronic bronchitis. Sold through retail pharmacies across China.
• 复方门冬维甘滴眼液 (Compound Menadione Eye Drops) OTC ophthalmic preparation (复方门冬维甘滴眼液) under the 闪亮 (Shanliang) eye care brand series, used for anti-fatigue and reducing conjunctival congestion symptoms.
• 萘敏维滴眼液 (Naphazoline Eye Drops) OTC ophthalmic preparation under the 闪亮 (Shanliang) eye care brand series, used for relieving eye fatigue, conjunctival充血 (congestion), and eye itching symptoms.
• 布洛芬混悬液 (Ibuprofen Suspension) OTC pediatric ibuprofen oral suspension under the 米阿卡 (Miaka) pediatric brand series. Indicated for fever from common cold or influenza in children, and for relieving mild to moderate pain (headache, joint pain, migraine, toothache, muscle pain, neuralgia, dysmenorrhea) in children.
• 盐酸氨溴索分散片 (Ambroxol Hydrochloride Dispersible Tablets) OTC cough expectorant under the 克快好 (Kekuaihao) cough brand series, used to facilitate expectoration of viscous sputum that is difficult to clear.
• 川贝清肺糖浆 (Chuanbei Qingfei Syrup) OTC syrup under the 克快好 (Kekuaihao) cough brand series for clearing lung heat, moistening dryness, relieving cough, and resolving phlegm; indicated for dry cough and sore throat.
• 补益类OTC中成药产品组合 (Tonic OTC TCM Product Portfolio) OTC tonic product line (补益产品线) covering kidney yin/yang support (Liuwei Dihuang concentrated pills, Guifu Dihuang pills, Qiju Dihuang pills), kidney/longevity tonic (Bushen Yishou Pian, Zhuangyao Jianshen Pian), spleen and qi support (Buzhong Yiqi Wan, Codonopsis Poria capsules, Buqi Koufu Ye), bone and calcium supplements (oyster shell calcium chewable tablets 105 ct & 100 ct, Sanwei calcium gluconate phosphate chewable tablets, oral five-vitamin lysine glucose), yin-blood and yang nourishment (Guijia Jiao, Guilu Erxian Gao, Tortoise and Deer Two-Immortal Paste), folic acid, and Codonopsis Poria oral liquid. Distributed through retail pharmacies nationwide.
• 心脑血管慢性病产品组合 (Cardiovascular Chronic Disease Product Portfolio) OTC and prescription cardiovascular/chronic disease product line (慢病产品线) including ginkgo biloba soft capsules (improving cerebral blood flow and memory), levamlodipine besylate tablets (hypertension and angina), tortoise shell gelatin (nourishing yin, enriching blood, strengthening bones), and omeprazole enteric-coated tablets / esomeprazole magnesium enteric capsules (GERD and peptic ulcer). Distributed through retail pharmacies nationwide.
• 感冒类OTC药品组合 (Cold/Flu OTC Product Portfolio) OTC cold and flu product line (感冒类) including Compound Yinqiao Anmin capsules, Siji Ganmao capsules (Four-Season Cold capsules), paracetamol caffeine amantadine hydrochloride tablets, Tongxuan Lifei tablets (lung-diffusing and phlegm-resolving), and Huoxiang Zhengqi mixture/oral liquid (summer-heat and dampness relief). Distributed through retail pharmacies nationwide.
• 妇科类OTC中成药 (Gynecological OTC TCM) OTC gynecological TCM product line (妇科类) including Agui Yangxue granule (qi and blood deficiency in women), Danggui Futong Ning dropping pill (menstrual pain relief), and Fuyan Kangfu chewable tablet (gynecological inflammation). Distributed through retail pharmacies nationwide.
• 消化系统OTC药品 (Digestive System OTC)
• 外用膏剂OTC产品 (Topical Ointment OTC Portfolio) OTC topical musculoskeletal/ointment product line (外用膏剂类) including Shexiang Zhuanggu plaster (musk bone-strengthening plaster for pain relief, anti-inflammation, rheumatism, joint pain, and muscle soreness), Guanjie Zhitong plaster (joint pain relief), Die Da Wanhua oil (bruises, sprains, pain relief), ketoprofen patches (inflammation and rheumatism), new skin demodex ointment, and Gu You medicated patch. Distributed through retail pharmacies nationwide.
• 五官皮肤类OTC产品 (ENT/Skin OTC Portfolio) OTC ENT and skin product line (五官皮肤类) including Compound Ketoconazole ointment (body tinea, hand/foot tinea, jock itch), Shidu Qing tablets (skin itching from blood deficiency and dampness accumulation), Medical Type III Collagen Repair Dressing (skin repair and regeneration), Hyaluronic Acid Sodium Gel Dressing (skin hydration and wound healing), Medical Hyaluronic Acid Sodium Dressing (skin barrier repair), and Sodium Chloride eye drops (eye dryness relief). Distributed through retail pharmacies nationwide.
• 维生素矿物质类产品 (Vitamins & Minerals OTC Portfolio) OTC vitamins and minerals product line (维生素矿物质类) including folic acid tablets (nutritional supplementation), Vitamin EC tablets (antioxidant), Multi-vitamin and Mineral tablets/capsules (21 and 15 types for comprehensive nutritional support), Codonopsis Poria capsules, Compound Zinc Iron Calcium oral solution, Zinc Gluconate oral solution, and oral five-vitamin lysine glucose. Distributed through retail pharmacies nationwide.
• 清热解毒清火类产品 (Heat-clearing / Detox OTC Portfolio) OTC heat-clearing and detoxifying product line (清热解毒清火类) including Tibetan Chebulic Fruit throat lozenge (sore throat and pharyngitis), Banlangen granules (clearing heat, detoxifying, for colds and sore throat), Fengyoujing Essential Oil (cooling, pain relief, mosquito bites), and various clear-heat formulas. Distributed through retail pharmacies nationwide.
• 止咳化痰类OTC产品 (Cough & Expectorant OTC Portfolio) OTC cough and expectorant product line (止咳化痰类) including acetylcysteine granules (dissolving phlegm), Juhong granules (resolving phlegm for phlegm-dampness cough), Guilong Kechuanning tablets, Fufang Kechuan capsules, diclofenac sodium aerosol (muscle/soft tissue/joint pain), Compound Yinqiao Anmin capsules, and other cough/asthma remedies. Distributed through retail pharmacies nationwide.
• 抗生素类OTC产品 (Antibiotics OTC Portfolio) OTC antibiotic product line (抗生素消炎类) including levofloxacin hydrochloride tablets (bacterial infection treatment) and cephalosporin/penicillin-class antibiotics distributed through retail pharmacies nationwide under appropriate pharmacist supervision.
• 盐酸左氧氟沙星片 (Levofloxacin Hydrochloride Tablets) OTC antibiotic tablet (盐酸左氧氟沙星片) for treating bacterial infections. Sold through retail pharmacies nationwide.
• 枸橼酸西地那非口崩片 (Sildenafil Citrate Oral Disintegrating Tablet) OTC urology product (泌尿类) — sildenafil citrate oral disintegrating tablet indicated for erectile dysfunction. Distributed through retail pharmacies nationwide.
• 桂附地黄丸 (Guifu Dihuang Wan) OTC Chinese patent medicine (Guifu Dihuang pill) for warming and tonifying kidney yang, part of the 补益 (tonic) product line. Sold through retail pharmacies nationwide.
• 杞菊地黄丸 (Qiju Dihuang Wan) OTC Chinese patent medicine (Qiju Dihuang pill) for nourishing liver and kidney yin, indicated for dizziness and vision problems, part of the 补益 (tonic) product line. Sold through retail pharmacies nationwide.
• 盐酸氨溴索分散片 (Kekuaihao Brand) OTC ambroxol hydrochloride dispersible tablet under the 克快好 cough brand series, indicated for difficult-to-expectorate viscous sputum. Sold through retail pharmacies nationwide.

Quantifiable outcome

• 262 products on market across 10+ therapeutic series
• +1 more outcomes

Named customers1 record

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Two partnerships are on record, tiered core.

• 安徽邻医数智科技有限公司coreTechnology or Integration · 24 March 2026仁和中方 entered into a strategic cooperation with 安徽邻医数智科技有限公司 to launch a 全渠道合规管控直连系统 (full-channel compliance management direct connection system). The system provides full-process price monitoring, intelligent violation identification, refined sales entity management, and data analysis optimization. It aims to enable dynamic monitoring and timely warnings, prevent market irregularities, and drive digital transformation in compliance management. The signing ceremony was held on March 24, 2026, at Renhe headquarters in Zhangshu, Jiangxi. Both companies' core management teams attended.
• 中国医药物资协会coreOthers仁和中方医药股份有限公司 is a vice-chairman unit (副会长单位) of the China Medical Materials Association (中国医药物资协会), indicating a high-level institutional partnership that provides industry representation, networking, and influence within China's pharmaceutical distribution sector.

Scale indicators6 records

Recent moves7 records

Expansion highlights4 records

Broad incumbents

• China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. A major Chinese OTC and traditional Chinese medicine company with branded products sold through pharmacies and other retail channels. It is comparable in OTC product positioning and pharmacy customer base, though it is primarily a product company rather than a pure distributor.
• Yunnan Baiyao Group Co., Ltd. A leading Chinese consumer-health and TCM brand with broad pharmacy and retail distribution. It competes for the same OTC consumers and shelf space, while the subject is more focused on wholesale marketing across a parent portfolio.
• Sinopharm Group Co., Ltd. A large integrated pharmaceutical distributor and retailer with hospital, pharmacy and consumer-health channels. It overlaps with the subject's national drug distribution and retail-pharmacy exposure but operates at substantially greater scale and breadth.
• China Resources Pharmaceutical Group Limited: A large integrated pharmaceutical and healthcare group with distribution, retail, manufacturing and consumer-health activities. It offers relevant scale and channel overlap but is broader and more diversified than Renhe Zhongfang.
• Shanghai Pharmaceuticals Holding Co., Ltd. An integrated pharmaceutical group spanning manufacturing, distribution and retail services. Its broad pharmaceutical and OTC portfolio and healthcare-provider distribution are comparable to the subject's marketing-and-wholesale role, though the subject is more concentrated in Renhe-branded OTC products.
• Jiangzhong Pharmaceutical Co., Ltd. An established TCM and OTC consumer-health company with a strong pharmacy and retail presence. Its branded health products make it a relevant benchmark for the subject's OTC portfolio and terminal sell-through strategy.

Direct peers

• Jointown Pharmaceutical Group Co., Ltd. A major Chinese pharmaceutical distributor and wholesaler supplying pharmacies, hospitals and other healthcare customers. Its account-based, nationwide distribution model closely matches the subject's OTC pharmacy-channel focus, although Jointown is larger and more logistics-heavy.
• China Meheco Co., Ltd. A national pharmaceutical distribution and trading platform serving healthcare institutions and downstream customers. It is comparable in account-based distribution and product breadth, with more institutional and import/export exposure than the subject.
• Guangzhou Pharmaceutical Group Co., Ltd. An integrated Chinese pharmaceutical group with wholesale, retail and own-brand TCM and OTC products. Its pharmacy distribution and branded consumer-health portfolio overlap directly with the subject's national OTC marketing model.

Regional players

• Nanjing Pharmaceutical Co., Ltd. A Chinese pharmaceutical wholesaler and distribution enterprise focused on pharmacy and healthcare-provider customers. It is comparable in drug distribution and account management, but its geographic footprint is more regional than the subject's stated nationwide network.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/%E4%BB%81%E5%92%8C%E4%B8%AD%E6%96%B9%E5%8C%BB%E8%8D%AF%E8%82%A1%E4%BB%BD%E6%9C%89%E9%99%90%E5%85%AC%E5%8F%B8

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about 仁和中方医药股份有限公司